Academic Journal
Q1Nature Cancer
About Nature Cancer
Nature Cancer is a scholarly journal published by Nature Research. SCImago 2025 lists it in Q1, with an SJR of 12.443 and H-index of 102.
Coverage: 2020-2026. Research categories: Cancer Research (Q1); Oncology (Q1).
Journal Metrics
Metrics can change by reporting year. Verify time-sensitive values with the publisher or indexing service.
Aims & Scope
Scope information will be added after verification.
Recent Research Articles
Latest publications matched automatically by ISSN.
l-Glutamine’s potential to enhance chemotherapy efficacy in advanced pancreatic cancer
2026-09-01 · DOI: 10.1038/s43018-026-01231-1SlideChat is a multimodal generative artificial intelligence assistant for whole-slide computational pathology across cancer types
Ying Chen, Chenglong Ma, Qiongqiong Li, Fang Yan et al.
2026-09-01 · DOI: 10.1038/s43018-026-01220-4Publisher Correction: Adjuvant personalized multivalent neoantigen DNA vaccination for MGMT unmethylated glioblastoma: a phase 1 trial
Elizabeth A. R. Garfinkle, Renzo Perales-Linares, Ryan C. Gimple, Alexandra J. Livingstone et al.
2026-09-01 · DOI: 10.1038/s43018-026-01243-xl-Glutamine in combination with first-line gemcitabine and nab-paclitaxel in advanced pancreatic ductal adenocarcinoma: an open-label, single-arm, phase 1 GlutaPanc trial
Jun Gong, Hayato Muranaka, So Yung Choi, Mourad Tighiouart et al.
2026-08-31 · DOI: 10.1038/s43018-026-01225-zAuthor Correction: Low-protein diet enhances antitumor immunity in pancreatic cancer through microbiota-derived UDP-galactose
Yueying Chen, Fulin Nian, Shengdi Wu, Tianli Yuan et al.
2026-08-25 · DOI: 10.1038/s43018-026-01241-zGalanin impairs tumor immunity in glioblastoma by promoting infiltration and ferroptosis resistance of myeloid-derived suppressor cells
Lizhi Pang, Yang Liu, Fei Zhou, Songlin Guo et al.
2026-08-25 · DOI: 10.1038/s43018-026-01221-3Coming full circle
Paul S. Mischel
2026-08-21 · DOI: 10.1038/s43018-026-01219-xRewiring immunity with in vivo CAR T cell engineering
Clare Y. Slaney, Rachel Xu, Shiyi Wu, Kevin Sek et al.
2026-08-21 · DOI: 10.1038/s43018-026-01216-0A lactate–α-ketoglutarate metabolic circuit in tumor-infiltrating regulatory T cells accelerates tumor progression by inducing NK cell senescence
Tiezhu Shi, Yufeng Ding, Ying Chen, Xiangyin Tan et al.
2026-08-18 · DOI: 10.1038/s43018-026-01210-6Low-protein diet enhances antitumor immunity in pancreatic cancer through microbiota-derived UDP-galactose
Yueying Chen, Fulin Nian, Shengdi Wu, Tianli Yuan et al.
2026-08-17 · DOI: 10.1038/s43018-026-01222-2Local AI agent brings tumor board expertise to hematological malignancies
Sha Yu
2026-08-13 · DOI: 10.1038/s43018-026-01228-wIntegrating AI in clinical decision-making
Vincenzo Giacco
2026-08-12 · DOI: 10.1038/s43018-026-01230-2TIM3-targeted delivery of venetoclax overcomes drug resistance and reinvigorates NK cell activity in acute myeloid leukemia
Qiwei Wang, Jingyi Li, Xin Zeng, Lina Liu et al.
2026-08-12 · DOI: 10.1038/s43018-026-01217-zCharting intratumor heterogeneity from bench to bedside
Jonathan C. M. Wan, Nicholas McGranahan, Charles Swanton
2026-08-07 · DOI: 10.1038/s43018-026-01198-zTumoral extracellular vesicles and particles reprogram interstitial macrophages in the lung to promote vascular permeability and metastasis
Shani Dror, Inbal Wortzel, Serena Lucotti, Yura Seo et al.
2026-08-05 · DOI: 10.1038/s43018-026-01209-zFc-optimized GITR antibody enhances a CD4 T cell–dendritic cell crosstalk to promote antitumor immunity
Yahel Avraham, Natasha Barth, Tzlil Yair Bar-On, Barak Toval et al.
2026-08-05 · DOI: 10.1038/s43018-026-01207-1Insights from the ESMO Targeted Anticancer Therapies Asia Congress 2026
Vincenzo Giacco
2026-08-05 · DOI: 10.1038/s43018-026-01215-1Author Correction: IDH1-mutant vaccine in newly diagnosed astrocytoma: final analysis of the multicenter, single-arm, open-label, first-in-human phase 1 NOA16 trial
Lukas Bunse, Katharina Lindner, Antje Wick, Angelika Freitag et al.
2026-08-03 · DOI: 10.1038/s43018-026-01227-xCopper dependency in leukemia metabolism
Sarada Achyutuni, Jian Xu
2026-08-03 · DOI: 10.1038/s43018-026-01205-3Retraction Note: Targeted activation of ferroptosis in colorectal cancer via LGR4 targeting overcomes acquired drug resistance
Hao Zheng, Jinming Liu, Qi Cheng, Qianping Zhang et al.
2026-07-29 · DOI: 10.1038/s43018-026-01224-0Reviews
Community Reviews
Version History
September 8, 2026 at 7:40 am
September 8, 2026